Institutional Ownership
Eupraxia Pharmaceuticals Inc
CUSIP 29842P105COMEPRXQ1 2026
13D / 13G Filings
7
Schedule 13D/13G on record
Beneficial Filers
6
Distinct reporting persons
Largest Stake
12.4%
Max % of class reported
Institutional Holders
54
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
7 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Manchester Management Company, LLC | 13G/A | 9.2% | 4.90M | SEC |
| 2 | Nov 14, 2025 | Beutel, Goodman &Amp; Co Ltd. | 13G | 8.0% | 4.06M | SEC |
| 3 | Nov 14, 2025 | Robert Disbrow | 13G/A | 7.0% | 3.57M | SEC |
| 4 | Nov 13, 2025 | Manchester Management Company, LLC | 13G | 10.9% | 5.84M | SEC |
| 5 | Sep 26, 2025 | Joseph S. Freedman | 13D/A | 10.2% | — | SEC |
| 6 | Nov 14, 2024 | Disbrow Robert | 13G | 8.6% | 3.09M | SEC |
| 7 | Nov 7, 2024 | Freedman Joseph S. | 13D | 12.4% | 4.84M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Affinity Asset Advisors, LLC | 1.59M | $11.50M |
| 2 | Balyasny Asset Management L.P. | 1.35M | $9.77M |
| 3 | Vivo Capital, LLC | 1.35M | $9.77M |
| 4 | Ikarian Capital, LLC | 1.21M | $8.79M |
| 5 | Great Point Partners LLC | 1.20M | $8.69M |
| 6 | Scotia Capital Inc. | 1.34M | $7.24M |
| 7 | Point72 Asset Management, L.P. | 967.6K | $7.01M |
| 8 | Ubs Group AG | 762.6K | $5.52M |
| 9 | Redmile Group, LLC | 700.0K | $5.07M |
| 10 | Rubric Capital Management LP | 691.2K | $5.00M |